Q4 2025 Holdings
Filed 2026-02-12 | 91 holdings | $215.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Calumet, Inc.(CLMT) | Common | 131428104 | $44.0M | 2,214,969 | 20.4% |
| Apollo Global Management, Inc.(APO) | Common | 03769M106 | $32.6M | 225,000 | 15.1% |
| Alphabet Inc(GOOG) | Common | 02079K107 | $28.7M | 91,420 | 13.3% |
| Syndax Pharmaceutical, Inc.(SNDX) | Common | 87164F105 | $8.7M | 415,000 | 4.0% |
| Xeris Biopharma Holdings, Inc.(XERS) | Common | 98422E103 | $7.6M | 970,000 | 3.5% |
| Travere Therapeutics, Inc.(TVTX) | Common | 89422G107 | $7.1M | 186,000 | 3.3% |
| Bridgebio Pharma, Inc.(BBIO) | Common | 10806X102 | $6.5M | 85,000 | 3.0% |
| Protagonist Therapeutics, Inc(PTGX) | Common | 74366E102 | $6.4M | 73,000 | 3.0% |
| JPMorgan Chase & Co.(JPM) | Common | 46625H100 | $6.3M | 19,477 | 2.9% |
| Janus Henderson AAA CLO ETF(JAAA) | Common | 47103U845 | $4.7M | 93,528 | 2.2% |
| Viridian Therapeutics, Inc.(VRDN) | Common | 92790C104 | $4.5M | 145,000 | 2.1% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | Common | 14888U101 | $4.4M | 189,000 | 2.0% |
| Cogent Biosciences Inc.(COGT) | Common | 19240Q201 | $3.6M | 102,000 | 1.7% |
| Arcus Biosciences, Inc.(RCUS) | Common | 03969F109 | $2.9M | 121,241 | 1.3% |
| Alkermes PLC(ALKS) | Common | G01767105 | $2.7M | 95,000 | 1.2% |
| DocGo, Inc.(DCGO) | Common | 256086109 | $2.3M | 2,670,850 | 1.1% |
| Cybin Inc(HELP) | Common | 23256X407 | $2.3M | 285,182 | 1.1% |
| Cytokinetics, Incorporated(CYTK) | Common | 23282W605 | $2.2M | 34,000 | 1.0% |
| AtriCure, Inc.(ATRC) | Common | 04963C209 | $2.0M | 51,400 | 0.9% |
| AllianceBernstein Holding L.P.(AB) | Common | 01881G106 | $1.8M | 48,000 | 0.9% |
| Arcellx Inc(ACLX) | Common | 03940C100 | $1.7M | 25,700 | 0.8% |
| Spdr S&P Biotech ETF(XBI) | Common | 78464A870 | $1.6M | 13,000 | 0.7% |
| Tectonic Therapeutic, Inc.(TECX) | Common | 878972108 | $1.5M | 74,000 | 0.7% |
| Wave Life Science Ltd.(WVE) | Common | Y95308105 | $1.5M | 90,000 | 0.7% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $1.4M | 6,922 | 0.7% |
| TG Therapeutics, Inc.(TGTX) | Common | 88322Q108 | $1.3M | 45,000 | 0.6% |
| Vera Therapeutics, Inc.(VERA) | Common | 92337R101 | $1.3M | 26,000 | 0.6% |
| The Panagram Bbb-B CLO ETF(CLOZ) | Common | 81752T528 | $1.3M | 47,807 | 0.6% |
| Biohaven LTD(BHVN) | Common | G1110E107 | $1.3M | 110,720 | 0.6% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $1.2M | 22,000 | 0.5% |
| Madrigal Pharmaaceuticals, Inc.(MDGL) | Common | 558868105 | $1.2M | 2,000 | 0.5% |
| Adma Biologics, Inc.(ADMA) | Common | 000899104 | $1.1M | 60,200 | 0.5% |
| Biogen Inc.(BIIB) | Common | 09062X103 | $1.1M | 6,000 | 0.5% |
| Orchestra Biomed Holdings, Inc.(OBIO) | Common | 68572M106 | $1.0M | 250,000 | 0.5% |
| iShares Biotechnology ETF(IBB) | Common | 464287556 | $928.2K | 5,500 | 0.4% |
| Solid Bioscience Inc.(SLDB) | Common | 83422E204 | $916.2K | 162,440 | 0.4% |
| Lenz Therapeutics, Inc.(LENZ) | Common | 52635N103 | $859.7K | 53,732 | 0.4% |
| Pfizer Inc.(PFE) | Common | 717081103 | $805.2K | 32,337 | 0.4% |
| Rezolute, Inc.(RZLT) | Common | 76200L309 | $802.4K | 340,000 | 0.4% |
| Microsoft Corporation(MSFT) | Common | 594918104 | $773.8K | 1,600 | 0.4% |
| Apple Inc.(AAPL) | Common | 037833100 | $678.0K | 2,494 | 0.3% |
| Evolus, Inc.(EOLS) | Common | 30052C107 | $660.6K | 99,338 | 0.3% |
| Nektar Therapeutics(NKTR) | Common | 640268306 | $655.3K | 15,500 | 0.3% |
| International Business Machines(IBM) | Common | 459200101 | $634.5K | 2,142 | 0.3% |
| Scholar Rock Holding Corporation(SRRK) | Common | 80706P103 | $612.9K | 13,913 | 0.3% |
| Pelthos Therapeutics, Inc.(PTHS) | Common | 171126204 | $597.7K | 19,281 | 0.3% |
| Canadian Natural Resources Limited(CNQ) | Common | 136385101 | $568.7K | 16,800 | 0.3% |
| Connect Biopharma Holdings Limited(CNTB) | Common | G23549101 | $564.0K | 200,000 | 0.3% |
| Xenon Pharmaceuticals Inc.(XENE) | Common | 98420N105 | $491.3K | 10,962 | 0.2% |
| Agios Pharmaceutical, Inc.(AGIO) | Common | 00847X104 | $490.0K | 18,000 | 0.2% |